Some great talks in our final session of the day on interdisciplinary immunology. First was Dr Alastair Corbin from Pathios Therapeutics, 'Targeting Acidic Immune Suppression in Cancer with PTT-4256: a first-in-class small molecule inhibitor of GPR65'. #OIS25
6 months ago